The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between immune-related adverse events and microbiome composition in patients with advanced non–small cell lung cancer treated with immunotherapy.
 
Marion Tonneau
No Relationships to Disclose
 
Corentin Richard
No Relationships to Disclose
 
Alexis Nolin-Lapalme
No Relationships to Disclose
 
Edouard Auclin
Consulting or Advisory Role - Amgen; Sanofi
 
Myriam Benlaifaoui
No Relationships to Disclose
 
Mayra Ponce
No Relationships to Disclose
 
Afnan Al-Saleh
No Relationships to Disclose
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Merck; Novartis; Pfizer; Roche Canada; Sanofi; Takeda
Research Funding - AstraZeneca (Inst)
 
Marie Florescu
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
 
Mustapha Tehfe
Honoraria - Bristol-Myers Squibb; Celgene; Eisai; Merck; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Merck; Taiho Pharmaceutical; Takeda
Research Funding - Celgene
 
Julie Malo
No Relationships to Disclose
 
Meriem Messaoudene
No Relationships to Disclose
 
Yusuke Okuma
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); Chugai Pharma (Inst)
 
Taiki Hakozaki
No Relationships to Disclose
 
Bertrand Routy
Consulting or Advisory Role - Da Volterra; EverImmune; Kaleido Biosciences; Vedanta Biosciences